Filing Flows › Gyre Therapeutics (GYRE) › Net income
Gyre Therapeutics (GYRE) net income by quarter
Gyre Therapeutics' net income was $5.9M in Q3 2025 (third quarter 2025), +277% from Q2 2025. Over the last 3 quarters it ranged from $1.6M (Q2 2025) to $5.9M (Q3 2025).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2025 | $5.9M | +277% | — |
| Q2 2025 | $1.6M | -58% | — |
| Q1 2025 | $3.7M | — | — |
Q3 2025 at a glance
Gyre Therapeutics, Q3 2025: revenue $30.6M (+20% year over year), operating margin 22.7%, net earnings $5.9M, operating cash flow $4.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Gyre Therapeutics' net income?
Gyre Therapeutics' net income was $5.9M in Q3 2025 (third quarter 2025), +277% from Q2 2025.
How has Gyre Therapeutics' net income changed?
Over the last 3 quarters it ranged from $1.6M (Q2 2025) to $5.9M (Q3 2025).